Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 28 04:00PM ET
10.73
Dollar change
+0.18
Percentage change
1.71
%
IndexRUT P/E- EPS (ttm)-4.01 Insider Own34.69% Shs Outstand134.78M Perf Week10.73%
Market Cap1.46B Forward P/E- EPS next Y-3.90 Insider Trans-0.35% Shs Float88.86M Perf Month30.38%
Income-539.44M PEG- EPS next Q-0.90 Inst Own53.04% Short Float6.99% Perf Quarter-6.12%
Sales79.60M P/S18.34 EPS this Y26.22% Inst Trans-5.29% Short Ratio6.57 Perf Half Y9.94%
Book/sh11.39 P/B0.94 EPS next Y-15.11% ROA-24.19% Short Interest6.21M Perf Year-58.36%
Cash/sh8.55 P/C1.26 EPS next 5Y7.00% ROE-30.67% 52W Range7.61 - 27.48 Perf YTD6.66%
Dividend Est.- P/FCF- EPS past 5Y-34.12% ROI-32.56% 52W High-60.95% Beta0.51
Dividend TTM- Quick Ratio12.90 Sales past 5Y421.39% Gross Margin70.74% 52W Low41.00% ATR (14)0.53
Dividend Ex-DateAug 25, 2010 Current Ratio12.90 EPS Y/Y TTM-273.48% Oper. Margin-750.59% RSI (14)60.87 Volatility7.02% 5.07%
Employees587 Debt/Eq0.08 Sales Y/Y TTM-82.16% Profit Margin-677.69% Recom1.78 Target Price29.75
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q54.27% Payout- Rel Volume0.81 Prev Close10.55
Sales Surprise381.34% EPS Surprise54.35% Sales Q/Q-10.45% EarningsMay 02 AMC Avg Volume945.20K Price10.73
SMA209.58% SMA5013.27% SMA2008.40% Trades Volume767,613 Change1.71%
Date Action Analyst Rating Change Price Target Change
Jan-29-24Downgrade JP Morgan Overweight → Neutral $23 → $9
Sep-08-23Downgrade BofA Securities Buy → Neutral $23 → $14
Mar-06-23Upgrade JP Morgan Neutral → Overweight $35 → $34
Feb-21-23Upgrade Goldman Neutral → Buy $41 → $53
Jan-27-23Upgrade Morgan Stanley Underweight → Equal-Weight $18 → $30
Sep-14-22Initiated SVB Leerink Outperform $40
Sep-09-22Initiated Morgan Stanley Underweight $15
Mar-03-22Upgrade Robert W. Baird Underperform → Neutral $36 → $28
Dec-21-21Downgrade Robert W. Baird Neutral → Underperform $36
Oct-25-21Upgrade JP Morgan Underweight → Neutral $29 → $37
May-23-24 04:05PM
May-22-24 08:05AM
May-21-24 08:17AM
May-13-24 07:21PM
May-09-24 10:46AM
09:55AM Loading…
May-07-24 09:55AM
May-03-24 01:05PM
06:05AM
04:06AM
May-02-24 09:56PM
06:05PM
04:05PM
Apr-30-24 04:05PM
Apr-24-24 12:00PM
Apr-18-24 08:00AM
04:30PM Loading…
Apr-11-24 04:30PM
Apr-04-24 07:01PM
Mar-22-24 07:00AM
Mar-19-24 02:58PM
Mar-13-24 11:07AM
Mar-05-24 08:05AM
Feb-23-24 01:54PM
10:34AM
09:55AM
08:05AM
Feb-22-24 05:50PM
04:05PM
Feb-20-24 04:30PM
Feb-14-24 03:45PM
Feb-01-24 04:05PM
11:32AM Loading…
Jan-15-24 11:32AM
Dec-17-23 07:00AM
07:00AM
Dec-13-23 04:05PM
Dec-06-23 04:05PM
Nov-30-23 06:10AM
Nov-13-23 08:00AM
Nov-10-23 08:00AM
Nov-08-23 08:05AM
Nov-04-23 11:42AM
Nov-03-23 09:02AM
Nov-02-23 07:00PM
04:05PM
Oct-30-23 08:00AM
Oct-23-23 02:50AM
Oct-12-23 04:05PM
Oct-11-23 08:00AM
Oct-05-23 04:30PM
Oct-03-23 07:59AM
Sep-20-23 08:00AM
Sep-19-23 05:07AM
Sep-08-23 09:34AM
Aug-29-23 04:30PM
Aug-12-23 11:05AM
Aug-11-23 10:15AM
Aug-07-23 06:03AM
Aug-04-23 01:40PM
Aug-03-23 06:05PM
04:05PM
Jul-26-23 04:05PM
Jul-21-23 10:11AM
Jul-20-23 04:50PM
11:31AM
08:00AM
Jun-29-23 09:00AM
Jun-25-23 08:00AM
Jun-24-23 05:30AM
Jun-21-23 08:00PM
Jun-07-23 02:13AM
Jun-05-23 04:05PM
May-17-23 04:05PM
May-16-23 09:25AM
May-15-23 08:35AM
08:00AM
May-11-23 08:30AM
May-10-23 02:07PM
May-04-23 07:45PM
05:48PM
04:05PM
May-03-23 04:05PM
May-02-23 09:00AM
Apr-28-23 10:00AM
Apr-27-23 10:03AM
Apr-26-23 08:00PM
Apr-11-23 04:05PM
Apr-05-23 01:40PM
Mar-29-23 08:40AM
Mar-21-23 02:33PM
Mar-08-23 04:05PM
Mar-05-23 07:30AM
Mar-03-23 06:57PM
Feb-28-23 04:05PM
Feb-26-23 07:13AM
Feb-23-23 05:35PM
04:05PM
Feb-22-23 08:30AM
Feb-20-23 10:00AM
Feb-16-23 04:05PM
10:01AM
08:30AM
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
De Backer MarianneChief Executive OfficerApr 03 '24Sale9.4672,995690,365678,457Apr 04 04:14 PM
HANLY ANN M.EVP & Chief Technology OfficerApr 01 '24Sale10.052,71127,251132,069Apr 02 08:58 PM
Lee SungEVP & Chief Financial OfficerMar 27 '24Sale9.896,00859,404100,492Mar 28 12:18 PM
SCANGOS GEORGE ADirectorFeb 26 '24Sale11.6517,722206,522112,989Feb 26 07:30 PM
Pang PhillipEVP & Chief Medical OfficerFeb 22 '24Sale10.0514,568146,344250,111Feb 26 07:31 PM
HANLY ANN M.EVP & Chief Technology OfficerFeb 22 '24Sale10.0512,296123,521134,780Feb 26 07:34 PM
SCANGOS GEORGE ADirectorFeb 22 '24Sale10.0510,028100,737130,711Feb 26 07:30 PM
SCANGOS GEORGE ADirectorFeb 20 '24Sale10.2216,872172,385140,739Feb 20 09:02 PM
SCANGOS GEORGE ADirectorFeb 16 '24Sale10.2410,878111,386157,611Feb 20 09:02 PM
Pang PhillipEVP & Chief Medical OfficerFeb 16 '24Sale10.243,32134,006264,679Feb 16 06:56 PM
Pang PhillipEVP & Chief Medical OfficerJan 02 '24Option Exercise1.3880,000110,299268,000Jan 03 02:47 PM
SATO VICKI LDirectorJun 30 '23Sale24.6618,000443,9161,315,351Jul 03 04:15 PM
SVF Endurance (Cayman) Ltd10% OwnerJun 30 '23Sale25.1170017,57716,684,041Jul 05 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJun 29 '23Sale25.1889,9422,264,73116,684,741Jun 30 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJun 28 '23Sale25.107,010175,92216,774,683Jun 30 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJun 20 '23Sale25.189,902249,30216,781,693Jun 22 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJun 16 '23Sale25.43128,1443,258,98016,791,595Jun 20 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJun 15 '23Sale25.8555,1821,426,68016,919,739Jun 20 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJun 14 '23Sale26.1357,2481,495,61816,974,921Jun 15 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJun 13 '23Sale27.09106,8542,894,18017,032,169Jun 15 09:00 PM
Pang PhillipChief Medical OfficerJun 07 '23Option Exercise1.535,0007,650193,000Jun 08 04:30 PM
Pang PhillipChief Medical OfficerJun 07 '23Sale25.955,000129,727188,000Jun 08 04:30 PM
SVF Endurance (Cayman) Ltd10% OwnerJun 05 '23Sale27.325,197141,99817,139,023Jun 06 09:00 PM
SVF Endurance (Cayman) Ltd10% OwnerJun 02 '23Sale27.3234,365938,73217,144,220Jun 06 09:00 PM
Ramasastry SairaDirectorJun 01 '23Sale25.673,50089,84510,619Jun 02 12:19 PM
Rice Steven J.Chief Administrative OfficerJun 01 '23Sale25.672,50064,175106,840Jun 02 12:20 PM